adenoid cystic carcinoma type-1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

97,308 results for “adenoid cystic carcinoma type-1”

Trials

View all 69947 →

Active, not recruiting

Amivantamab in Adenoid Cystic Carcinoma

21 participants · First posted Oct 12, 2021

Dovitinib in Adenoid Cystic Carcinoma

33 participants · First posted Aug 16, 2011

Study of RAD001 in Adenoid Cystic Carcinoma

33 participants · First posted Jun 29, 2010

Drugs

View all 7846 →

Poliovirus type 1 antigen (formaldehyde inactivated)(Ipol, Kinrix, Pediarix, Pentacel, Quadracel, Vaxelis)

Conditions: Poliomyelitis caused by Poliovirus, Poliomyelitis caused by poliovirus type 1

type-1 diabetes program

Organizations

View all 1408 →

Cystic Fibrosis Foundation

United States

NHI-1

United States

Xi'an No.1 Hospital

China

News

View all 18107 →

Day One Biopharmaceuticals Acquires Mersana Therapeutics for $285 Million to Advance Novel ADC for Rare Cancer

Day One Biopharmaceuticals Acquires Mersana Therapeutics for $129M, Targeting Rare Cancer Treatment

NextCure Advances Two ADC Programs with Q2 2026 Data Readout Expected for CDH6-Targeted Therapy

Page 1 of 9731